Dijklander Ziekenhuis — Clinical Trial Site

34 Registered trials

16 Currently recruiting

Organisation

Dijklander Ziekenhuis

Location

Hoorn Nh, Netherlands

Identifier

ORG-100044188

Address

Maelsonstraat 3, 1624 NP, Netherlands

Departments

Cardiology
Center for Oncology
chirurgie
Department of Internal Medicine
Department of Medical Oncology
Gynaecology
Hematology
ICU
Internal Medicine
Interne geneeskunde
Medical oncology
Medische Oncologie
N/A
Oncology
Pneumology
Pulmonary Medicine
Pulmonology
Reproductive Medicine and Gynaecology
Surgery
Vasculair Onderzoek Centrum Hoorn
Vasculaire Geneeskunde

Clinical trials at this site (34)

Search interface

Liposomal iRInotecan, Carboplatin or oXaliplatin in the first line treatment of esophagogastric cancer: a randomized phase 2 study (LyRICX) Ended

2023-509287-26-00 previously untreated metastatic or locally advanced eso 4 2019-07-01
HOVON 152 DLBCL. A phase II study evaluating the effect of DA-EPOCH-R induction followed by nivolumab consolidation in patients with newly d… Ended

2022-501038-48-00 Diffuse Large B-Cell Lymphoma 4 2018-07-26
Endocrine therapy plus CDK 4/6 inhibition in first- or second-line for hormone receptor positive advanced breast cancer - the SONIA study Ended

2024-516204-42-00 Breast cancer 5 2017-11-21
Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) Ended

2023-507889-89-00 Respiratory tract infection 5 2016-02-19
Biomarker discovery randomized phase IIb trial with carboplatin-cyclophosphamide versus paclitaxel with or without atezolizumaB as first-lin… Ended

2024-516202-39-00 Metastatic breast cancer 4 2013-10-10
GENPAD Ended

2024-518122-33-00 Peripheral Arterial Disease 6 2024-12-13
A clinical study of MK-0616 for people with high amounts of low-density lipoprotein cholesterol Ended

2022-502782-14-00 Heterozygous Familial Hypercholesterolemia (HeFH) 5 2023-09-28
A Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Ended

2023-507093-40-00 Chronic Obstructive Pulmonary Disease (COPD) 4 2022-01-27
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24
Pembrolizumab Alone versUs pembrolizumab-chemotherapy in first LInE NSCLC (PAULIEN) Ended

2024-516581-11-00 Advanced stage NSCLC 5